| Income Statement for Barrier Therapeutics Inc. (BTRX) | | | | | | | Income | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Operating Revenue | 24,082 | 6,738 | 2,540 | 897 | 367 | | Adjustments to Revenue | - | - | - | - | - | | Cost of Revenue | (2,417) | (547) | 1,093 | 2,382 | 342 | | Gross Operating Profit | 21,665 | 6,191 | 3,633 | 3,278 | 709 | | | Selling/General/Admin Expense | (49,630) | (35,795) | (20,280) | (11,474) | (3,730) | | Research & Development | (27,900) | (25,895) | (30,369) | (30,904) | (17,484) | | EBITDA | (55,865) | (55,499) | (47,016) | (39,100) | (20,506) | | Depreciation & Amortization | (775) | (884) | (1,637) | (2,382) | (342) | | EBIT | (56,640) | (56,383) | (48,653) | (41,482) | (20,848) | | Interest Income | 2,127 | 3,015 | 2,929 | 1,409 | 419 | | Other Income, Net | - | - | - | - | - | | Total Income Avail For Interest Expense | (54,513) | (53,368) | (45,724) | (40,073) | (20,429) | | Interest Expense | (229) | (61) | (53) | (36) | (3) | | Pre-Tax Income | (54,742) | (53,429) | (45,777) | (40,110) | (20,432) | | Income Taxes | 1,050 | 655 | 536 | 367 | 217 | | Minority Interest | - | - | - | - | - | | Net Income from Continuing Operations | (53,692) | (52,774) | (45,241) | (39,743) | (20,215) | | Net Income from Discontinued Operations | - | - | - | - | - | | Net Income from Total Operations | (53,692) | (52,774) | (45,241) | (39,743) | (20,215) | | | Normalized Income | (53,692) | (52,774) | (45,241) | (39,743) | (20,215) | | Extraordinary Income | - | - | - | - | - | | Special Income/Charges | - | - | - | - | - | | Income from Cum. Effect of Acct Change | - | 57 | - | - | - | | Income from Tax Loss Carryforward | - | - | - | - | - | | Other Gains | - | - | - | - | - | | Total Net Income | (53,692) | (52,717) | (45,241) | (39,743) | (20,215) | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | - | - | 4,592 | 8,432 | | | Basic EPS from Continuing Operations | -1.74 | -2.06 | -1.91 | -3.02 | -83.95 | | Basic EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Basic EPS from Total Operations | -1.74 | -2.06 | -1.91 | -3.02 | -83.95 | | | Diluted EPS from Continuing Operations | -1.74 | -2.06 | -1.91 | -3.02 | -83.95 | | Diluted EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Diluted EPS from Total Operations | -1.74 | -2.06 | -1.91 | -3.02 | -83.95 | | | |
